Early prostate cancer - Treat or watch?

New England Journal of Medicine

Volumn 365, Issue 6, 2011, Pages 569-

  Klotz, Laurence ^a   Thompson, Ian ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ASPIRATION BIOPSY; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; EARLY CANCER; HUMAN; LETTER; LOW RISK PATIENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SCANDINAVIA;

EID: 80051621459     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1106560     Document Type: Letter

References (2)

1. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-31.
2. Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011;185:869-75.